novel approaches to screening for food contaminants · han van egmond: the netherlands luis botana:...
TRANSCRIPT
Broad Spectrum Testing for Compounds
The requirement to test for more chemical contaminants in food in a shorter period of time has become a necessity within routine laboratories.
How can we achieve this?
Broad Spectrum Contaminant Analysis
In their wise & far sighted approach to the subject the European Commission published in the FP6 Food Quality Work Programme:
“New methods to prevent & monitor occurrence of multiple contaminants such as pesticides, toxins, drugs, & EDs in foods.
This should be achieved through use of advanced sample preparation techniques & emerging biotechnological screening approaches based on development of novel biomarkers”
Question…….
How can such a radical set of requirements be met?
The birth of the Biocop consortium……….
The Biocop principles:
The fundamental scientific objective is to utilise emerging life science technologies to create a powerful new approach to detect & control chemical contaminants in foods.
Biocop: New Technologies to Screen Multiple Chemical Contaminants in Foods
Objectives:
Development of novel screening methods to detect multiple chemical contaminants in foods
Training of scientists in developed technologies
Widespread dissemination of project information
Project Architects
Hanspeter Naegli: Switzerland
Aldert Bergwerff: The Netherlands
Timo Lovgren: Finland
Esa Stenberg: Sweden
Han van Egmond: The Netherlands
Luis Botana: Spain
Matthew Sharman: United Kingdom
Michel Nielen: The Netherlands
Jana HajŠlová: Czech Republic
Edwin de Pauw: Belgium
Guiseppe Palleschi: Italy
Project Timelines
Written & submitted : May 2002 (1156 in food)
Shortlisted by EC : October 2002 (53 in food)
Appeared in FP6: Food Quality & Safety Work programme: December 2002
Specific call appeared in November 2003
The Current Status of the The Current Status of the BioCop BioCop ProposalProposal
Submitted February 2004
First phase of evaluation: Passed as top proposal
Second Phase evaluation: Passed as top proposal
Contract negotiations commenced with the Commission June 2004
The PlanThe Plan……....
Completion of contracts October 2004
Initiation of five year project from January 2005
33 partners from 16 countries
Budget 15M EURO (9.6M for European Commission)
BiocopBiocop: The Science: The Science
Veterinary drugs, heavy
metals, mycotoxins, EDs
shellfish toxins, pesticides,
Transcriptomics,
Proteomics, Molecular
Engineering, Biosensors
WP5 Shellfish Toxins
WP 10 Mycotoxins
WP6 Pesticides
WP8 Therapetics
WP7 Endocrine Disrupters
WP9 Heavy metals
WP1 WP2 WP3 WP4 Binding
Molecules
T’omics Proteomics Biosensors
WP11 Consumer Sci &
Dissemination
The The Biocop Biocop MatrixMatrix
Transcriptomics Transcriptomics (1)(1)Identification of chemical residues through genomic fingerprints
Exposure of Target Cells
cDNA
Total RNA isolation
In vitro
transcription
*biotin-labeled cRNA
Hybridization to the
Affymetrix®U133 GeneChip
(sequences of 33‘000 human genes)
��������
��������
�������� ��������
SAPE Staining
Scanning &
Data Analysis
Reverse transcription
TranscriptomicsTranscriptomics (2)(2)
The selected genes will then be employed to print tailored DNA microchips for the development of a low cost high-throughputmicroarray platform.
0 5
10
15
20
Induction
SFRS2
FLJ11838
JAK1
HNRPH3
MCM2
MELK
ANLN
HELLS
FLJ10055
SDF1
PIGA
DUT
CXCL12
IER3
HCAP-G
H11
SFXN2
GJA1
CTSD
FKBP4
OLFM1
SERPINA6
IGFBP4
MYB
HNOEL-iso
PTPLA
HSPC154
IGSF4
CDC6
NASP
RRM2
UHRF1
KIAA0101
ACAT2
MYBL
TYMS
TSSC3
AMD1
ARL3
FLJ10540
RAMP
genis
tein
bis
phenol A
Comparison betw
een bisphenol A, genistein and estradiol
Transcriptom
icsTranscriptom
ics(3)(3)
Proteomics Proteomics (1)(1)
Identification of candidate biomarkers
Development of methodology to screen animals for the presence of identified biomarkers
Selection of most appropriate biomarkers
Fingerprints reporting contamination of food-producing animals
catabolism ⇔ anabolismcatabolism ⇔ anabolismcatabolism ⇔ anabolismcatabolism ⇔ anabolism
Identification of alteration of protein expression using a wide range of proteomic tecnhiques
ProteomicsProteomics (2)(2)
•Species / race
•Zootechnical aspects
•Health
•Age
•Gender
•Feed regime
•Oestrous cycle
•Gestation
•Stress
•Concentration of the target substance
•…….
ProteomicsProteomics (3)(3)
Confusing signals…..
Source existing mabs Produce new panels of mabs
Gene ManipulationSource existing enzymes
DNA databases Receptor Expression
Assay Developers
Production of Unique Binding ProteinsProduction of Unique Binding Proteins
From a very compound specific antibody to a broad spectrum binding protein.
R&D work based at University of Turku
Antibody Engineering
A wide range of existing mabs available to the consortium. These will undergo engineering
The Fusion Technology PlatformThe Fusion Technology Platform
High-throughput
Platform
Receptor
Modelling
Fragments
cloned with
fusion tags
Over-express in
E. coli
solubility
Scale-up
low
pressure
purification
Incorporation
into assay
www.fusionantibodies.co.uk
BiosensorsBiosensors
Optical Optical ElectrochemicalElectrochemical
⇒⇒⇒⇒⇒⇒⇒⇒ High throughputHigh throughput
⇒⇒⇒⇒⇒⇒⇒⇒ Technology couplingTechnology coupling⇒⇒⇒⇒⇒⇒⇒⇒ Low cost Portable devicesLow cost Portable devices
Biosensors(3)Biosensors(3)
Identification & Quantification
Sample injection
Measurable molecular interactions
Immobilised receptor on chip surface
No response, no MS analysis
Biosensor Coupled to Mass Spectrometry
Phase 1: Research, e.g.
Development of binders, surface chemistries, chip production,
equipment design
Phase 2: Research, e.g.
Development of assays, technology coupling, sample preparation
Phase 3: Comparison and validation
Compare new assays with state of the art & fully validate
Phase 4: Demonstration
Technology transfer events, e.g. Workshops
YEAR
1
2
3
4
5
Decision Points Decision Points
Decision Points Decision Points
Decision Points Decision Points
BioCop BioCop PhasesPhases